MIT research shows positive results of skin patch for cancer treatment
Category: #research  By Nikita Chaurasia  Date: 2019-08-26
  • share
  • Twitter
  • Facebook
  • LinkedIn

MIT research shows positive results of skin patch for cancer treatment
  • The skin patch designed, demonstrated positive results in an experiment on mice and human skin samples.
  • The MIT researchers designed the patch to fight melanoma cancer.

Researchers at the Massachusetts Institute of Technology reportedly announced successful results of a skin patch developed to offer cancer treatment in mice & human skin samples at the American Chemical Society conference in California, San Diego.

Apparently, the researchers at the MIT designed the patch to fight melanoma, a fatal but treatable skin cancer. For the uninitiated, Melanoma is subjected to be caused by an extreme exposure to UV rays from the sun or other sources. It has been claimed that the patch is less than a centimeter long and covered with a gluey film, which allows it to be applied and detached from the skin within a minute.

As per trusted reports, the researchers of the organization used the patch to deliver a toxin in healthy mice and later compared the immune response to other treatment methods used to vaccinate against the flu and measles. The results of the skin patch presented a robust antibody response along with a strong immune response in human skin.

The lead author of the study and HOD of Chemical Engineering, MIT, Dr. Paula Hammond reportedly stated that the organization’s recently designed patch technology can be used to offer vaccines to fight against various infectious diseases. Additionally, the researchers are pleased by the possibility of the patch to win against melanoma cancer.

The patch is embedded with microneedles, developed through a layer-by-layer coating process. This provides the advantage over syringes for its painless, easy to administer and reduced infection risk characteristics.

The researchers claimed that the patch treatment produced over 9 times the level of infection-fighting antibodies while comparing to the intramuscular injections. Additionally, it also produced over 160 times the level of antibodies compared to subcutaneous injections.

Speculation has it that the research was aided by the U.S. Department of Defense along with the Koch Institute for Integrative Cancer Research at MIT and Singapore-MIT Alliance for Research and Technology.

Source credit: https://www.cnbc.com/2019/08/25/new-skin-patch-to-deliver-cancer-medicine-shows-promise-in-mice-mit-scientists-say.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Google to team up with two banks to offer smart checking accounts
Google to team up with two banks to offer smart checking accounts
By Nikita Chaurasia

The project is the extension of the digital payment system, Google Pay   It is an attempt to focus on tech-focused alternative for traditional banking Google plans to partner with two banks, the Stanford Federal Credit Union and Citigroup ...

Saudi Arabia kicks off the IPO of its state oil producer Saudi Aramco
Saudi Arabia kicks off the IPO of its state oil producer Saudi Aramco
By Nikita Chaurasia

Numerous high-revenue companies are increasingly looking towards launching their IPO lately, primarily owing to the benefits offered by the process, including raising equity capital, liquidity for employees and investors, branding and visibility, the...

SoftBank inks a deal to take control over 80% of WeWork ownership
SoftBank inks a deal to take control over 80% of WeWork ownership
By Nikita Chaurasia

SoftBank has reportedly invested nearly USD 11 billion in workspace startup and real estate. In January, when the company decided to invest in WeWork, it did a valuation of around USD 47 billion. Since then, growing investor concern over WeWork&rsquo...